In recent years the human and veterinary pharmaceutical market is facing the health problem of antibiotic resistance that is getting worse every day. Antibiotic resistance is the result of the ability of micro-organisms to resist antibiotic treatments. It is however a natural phenomenon that occurs as a result of changes in the physiology of the micro-organism (intrinsic resistance) or by genetic changes (acquired resistance).
The intensive, excessive and often inappropriate use of antibiotics in the human and veterinary fields has significantly accelerated the process of spreading resistant organisms, extending this phenomenon of public health globally. Some examples of incorrect use of antibiotics can be traced in their use in diseases where the necessary intake conditions are not met or as growth promoters in animals and fish.
Botanical products and preparations based on plants, algae, fungi or lichens are widely present on the European market in the form of food supplements. The american Food and Drug Administration (FDA) defines Botanical Drug (BD) as the plant material that can be used for the diagnosis, treatment, treatment or prevention of diseases and that may include plants, algae, macroscopic fungi or combination of them. A BD can be sold as a prescription drug or as a free sale OTC product. This second group includes the range of products Algatan® created by LT Natural Group®.